Product information

Current status:

Cancelled Post Market

Current status date:

2014-07-24

Original market date: ^{See footnote 1}

1996-08-21

Product name:

ULTRASE

DIN:

02203324 Electronic product monograph is not available

Company:

APTALIS PHARMA CANADA ULC
1380 Roddick Road, Suite 300
Markham
Ontario
Canada L3R 4G5

Class:

Human

Dosage form(s):

Capsule (Enteric-Coated)

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

OTC

American Hospital Formulary Service (AHFS): ^{See footnote 3}

56:16.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)

Active ingredient group (AIG) number:^{See footnote5}

0302964014